Featured Speakers:
Stephen Rees, Ph.D. - Director, Screening and Compound Profiling, GlaxoSmithKline, Harlow, UK
Sabrina Corazza, Ph.D. - Head, Enabling Technologies, Axxam SpA, Milan, Italy
Patrick Sexton, Ph.D. - Professor of Pharmacology, NHMRC Principal Research Fellow, Monash University, Melbourne, Australia
Wei Zheng, Ph.D. - Group Leader, Cellular Signaling Assays, NIH, National Human Genome Research Institute, Rockville, USA
Chris Bakal, Ph.D. - Postdoctoral Research Fellow, Howard Hughes Medical Institute and Department of Genetics, Harvard Medical School, Boston, USA
John Westwick, Ph.D. - President & Chief Scientific Officer, Odyssey Thera, San Ramon, USA
Daniel Durocher, Ph.D. - Investigator & Assistant Professor, Mount Sinai Hospital, Samuel Lunenfeld Research Inst., Toronto, Canada
Fritz Poulsen, Ph.D. - Research Director, Screening & Assay Technology, Discovery Biology Mgt. Novo Nordisk, Bagsværd, Denmark
Yaeta Endo, Ph.D. - Executive Director, Cell-Free Science and Technology Research Center, Ehime University, Matsuyama, Japan
Richard Eglen, Ph.D. - Vice President and General Manager, Drug Discovery Research Reagents, PerkinElmer Life and Analytical Sciences, Waltham, USA
Martina Bielefeld-Sevigny, Ph.D. - Director R&D, PerkinElmer Life and Analytical Sciences, Montreal, Canada
Join these leading cellular scientists and industry experts as we examine current and future trends in cellular science and its impact on drug discovery. Hear from your peers as they present novel and innovative applications for cell based HTS and discuss new solutions to accelerate your research. |
